Treatment of Parkinson's Disease with Urinary Urgency and Bladder Detrusor Overactivity

Parkinson's disease patients may present with increased urinary frequency, urinary urgency, and bladder detrusor overactivity. This clinical constellation requires a targeted treatment approach specific to the underlying bladder dysfunction.

Clinical Scenario

This protocol applies to patients with Parkinson's disease who present with increased urinary frequency, urinary urgency (sudden urge to urinate), and bladder detrusor overactivity. These lower urinary tract findings define the specific sub-population addressed here.

Treatment Approach — Partial Overview

For appropriate candidates, an intravesical injection procedure directed at the bladder detrusor may be considered. Patient-specific eligibility criteria and the full management algorithm — including prior therapy requirements — are detailed in the complete structured regimen.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1186/s42466-024-00325-4

Antimuscarinics such as Solifenacin, Trospium or Darifenacin can be considered for treatment of increased urinary frequency and urgency due to overactivity of the bladder detrusor in PD patients.

Intravesical injection of Botulinum toxin A may be considered for treatment of detrusor overactivity in patients who have inadequately responded to oral therapy attempts provided that the patient's motor and cognitive performance level allows for subsequent intermittent self-catheterization, if needed.

View source ↗